Biomarin Pharmaceutical reported $710.98M in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 10.79M 0.48M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 84.36M 6.68M
Amgen AMGN:US $ 4115M 98M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Bayer BAYN:GR € 10125M 332M
Biogen BIIB:US $ 1254.8M 83M
Biomarin Pharmaceutical BMRN:US $ 710.98M 2.95M
Bluebird Bio BLUE:US $ 13.5M 4.58M
Gilead Sciences GILD:US $ 2988M 8M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Neurocrine Biosciences NBIX:US $ 28.3M 1.8M
Ptc Therapeutics PTCT:US $ 16.44M 0.21M
Puma Biotechnology PBYI:US $ 7.62M 0.12M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
Ultragenyx Pharmaceutical RARE:US $ 15.08M 2.62M
United Therapeutics UTHR:US $ 89.9M 2.3M
Vertex Pharmaceuticals VRTX:US $ 321.62M 22.76M
YTE INCY:US $ 16.68M 0.02M